By the end of 2021, the global pharmaceutical industry had revenues crossing approximately $1.40 trillion. The entire world recognized the importance of healthcare and pharmaceuticals as it battled the COVID-19 pandemic in the last two years. With the industry coming out of the crippling effects of the pandemic, the pharmaceutical industry is estimated to grow to over $2.4 trillion by the end of 2029.
There is no doubt that the global COVID-19 pandemic had a profound impact on the pharmaceutical and healthcare market, which is expected to make its effects felt both in the short and long term. With demand changes, revisions in regulations, changes in the research and development process, and a shift towards telemedicine and online consultancies with doctors, the coming years are going to usher in a very different pharmaceutical industry worldwide.
This report - Analyzing the Global Pharmaceutical Industry 2022 - presents a complete analysis of the global pharmaceutical industry by setting up an industry demarcation and providing a study on marketing dynamic of the industry like segments active in the industry, competitive activity and the overall market outlook. The impact of the COVID-19 pandemic on the global pharmaceutical industry is looked at, and the industry is analyzed through industry statistics, industry value, industry segmentation, an analysis of market share, competitive landscape and an industry forecast.
The role played by the OTC pharmaceuticals in the global pharma industry is also explained in detail in the report with the intense marketing efforts prevalent in the industry in order to push the inclusion of OTC pharmaceuticals into the buy - store segment of home segments. The often competed and hotly contested area of Generics with the rapid proliferative competition from the low-cost suppliers in the emerging markets is also explained in this report with the forecast for the industry which looks upbeat.
We analyze the global pharmaceutical industry, the global OTC market and the global generics industry through industry value, market segmentation, sector forecast, and market trends.
Factors driving growth and change in the global pharmaceutical industry are analyzed. Factors looked at include the emergence of new product lines, reasons for industry growth, opportunities in various CNS disorders and oncology research, ongoing commercialization of dormant compounds along with a look at the role of biosimilars in the industry. Moving on, we also analyzed the various challenges facing the global pharmaceutical industry and how the industry is dealing with them.
An analysis of the key pharmaceutical markets is included in the report. We analyze each market through industry statistics, industry value analysis, geographic segmentation, industry trends, market share analysis, competitive landscape and an industry outlook. Over 20 pharmaceutical markets analyzed in our report include:
- Australia
- Brazil
- Canada
- China
- France
- Germany
- India
- Italy
- Japan
- Mexico
- New Zealand
- Norway
- Poland
- Russia
- Singapore
- South Africa
- South Korea
- Spain
- Sweden
- Taiwan
- United Kingdom
- United States
Moving on, a comprehensive analysis of the major industry players is undertaken. The players are analyzed through a corporate profile, an analysis of their major business segments, a financial analysis, and a SWOT analysis. Industry stalwarts like GlaxoSmithKline, Novartis, Abbott Laboratories, and many others are analyzed in the report.
With over 100 figures & tables, this highly insightful and analytical report Analyzing the Global Pharmaceutical Industry 2022 is a complete & up-to-date coverage of the Global Pharmaceutical Industry.
Table of Contents
Executive Summary
Companies Mentioned
- Abbott Laboratories
- AbbVie
- Amgen, Inc.
- Apotex, Inc.
- Aspen Pharmacare Holdings Limited
- Astellas Pharma
- AstraZeneca
- Aurobindo Pharma Ltd
- Baxter International
- Bayer AG
- Boehringer Ingelheim
- Bristol-Myers Squibb
- Chugai Pharmaceutical
- Cipla Ltd
- Daewoong Pharmaceutical Co Ltd.
- Daiichi Sankyo Company
- Dr. Reddy's Laboratories Limited
- Eisai Co., Ltd
- Eli Lilly and Company
- F. Hoffmann-La Roche
- Gedeon Richter
- GlaxoSmithKline Plc
- Johnson & Johnson
- Lupin Limited
- Merck & Co.
- Novartis AG
- Pfizer
- Pharmstandard OJSC
- Sanofi SA
- Shanghai Pharmaceuticals Holding Co. Ltd.
- Sumitomo Dainippon Pharma
- Sun Pharmaceutical Industries
- Takeda Pharmaceutical Company Limited
- Teva Pharmaceutical Industries
